Benchling Brand Guidelines: The MIT Student Start-Up That Built an R&D Cloud for Biotech

Three MIT students and a Y Combinator summer.

Benchling was founded in 2012 by three students at the Massachusetts Institute of Technology: Sajith Wickramasekara, Ashu Singhal and Cory Li, according to English Wikipedia. Their starting point was software for designing and analysing CRISPR gene-editing experiments. Wikipedia says the prototypes drew enthusiastic feedback from researchers at MIT and Stanford, and that the three co-founders then took part in the summer 2012 batch of Y Combinator, the start-up programme.

The company grew through a series of venture rounds, lettered A to F, between 2016 and 2021. Wikipedia records that Benchling filed a registration statement with the U.S. Securities and Exchange Commission in November 2021, but that it had not completed a public listing as of 2026. It remains a privately held company.

Benchling’s headquarters are in the SoMa district of San Francisco, with an East Coast office in Boston, Wikipedia says. In 2021 the company set up its headquarters for Europe, the Middle East and Africa in Zurich, Switzerland. A year later it added an office in Belfast by buying the local start-up Overwatch Research; the trade site HIT Consultant reported the deal on 24 February 2022, quoting Wickramasekara, as chief executive, saying the purchase would deepen Benchling’s presence in Europe and describing Overwatch’s software for in vivo studies.

The company frames its origin in its own words. Its founders, it says, had worked in academic labs and saw that while biology was advancing quickly, the software supporting it was not; Benchling says they went on to build “the first cloud platform designed for modern life sciences R&D.” That is the company’s description of itself, and we give it as such.

A notebook, a lab system and an AI layer.

Benchling’s products sit in the category of laboratory informatics. English Wikipedia describes it as an American software company that develops electronic lab notebook, lab management and cloud computing software for life sciences and biotechnology research and development.

The company’s own product list in 2026 is organised by area of work. Its website names modules including Benchling Bioresearch, Biologics, Bioprocess and In Vivo, alongside Benchling AI, Benchling Insights and a validated cloud offering for regulated work. Its pages also offer free learning tools for CRISPR guides, primers and sequence alignments, a reminder of where the company started.

Wikipedia says much of Benchling’s software is offered free of charge for academic use, and that by 2025 it was used by more than 200,000 scientists at more than 1,300 companies and 7,500 academic institutions. The company’s own about page gives the figure of more than 1,300 organisations, from emerging start-ups to global enterprises, and says its customers span biopharma, agriculture, materials and other fields working through biology.

Acquisitions have added pieces to the platform. In October 2024 Benchling bought PipeBio, a cloud-based bioinformatics platform from Horsens, Denmark, that lets scientists screen and analyse millions of sequences, according to a dated note from the Danish law firm Mazanti-Andersen; PipeBio now appears under its own name in Benchling’s product list. The company also runs its own customer conference, Benchtalk, and in 2025 published a round-up of everything it released there.

Outside observers have used the company’s own vocabulary. When HIT Consultant reported the Overwatch purchase in February 2022, it called Benchling a pioneer of the “R&D Cloud” and quoted the company as saying that many of its biopharma and contract-research customers were looking for a comprehensive offering, which the in vivo software was meant to help provide.

The newest layer is artificial intelligence. Benchling’s home page in 2026 speaks of “Science Foundries,” in which teams of software agents work alongside scientists on data capture, analysis and the hand-offs between one experiment and the next, and of connecting those agents to scientific models that predict structures and generate sequences. These are the company’s own descriptions of its product direction.

Software for the lab and the clinic.

Life-sciences software is sold to scientists, clinicians, regulators and procurement teams at once, and the way these companies present themselves reflects that mixed audience. Their websites and brochures tend to show clean dashboards on laptops and tablets, molecule renderings and data charts, and people in lab coats or at clinic desks looking at screens. The product, in other words, is usually shown as an interface rather than an object.

The colour schemes follow the same logic. Many of these brands set one or two bright product colours against a lot of white space, so that charts, buttons and status labels stand out, and they use plain sans-serif type that stays legible in dense tables. Product families are often split into named “clouds,” “suites” or “platforms,” each with its own sub-brand, so a single company can carry dozens of product names under one mark.

Much of the selling happens in person. The sector gathers at trade conferences such as the DIA Global Annual Meeting, which brings together people working on drug development and regulation; Bio-IT World, which focuses on data and computing in life-sciences research; and SLAS, the laboratory-automation and screening society’s conference. Larger vendors also run their own customer summits, with keynote stages, product launches and user sessions; Medidata, for example, says its NEXT conference grew out of a user group for its Rave software.

Ownership matters too: several of the companies in this round have changed hands, and some have been bought by larger groups while keeping their own names. The guides in this round set out who founded each company, who owns it now and what it makes, and they mark clearly which statements rest only on the company’s own word.

A mission stated in one line.

Benchling states its purpose in one line: its mission, the company says, is “to unlock the power of biotechnology.” Its about page goes on to say that it helps scientists bring together data, automation and AI, and that nearly half of its team comes from research and development. Those are the company’s self-descriptions.

The brand’s public face is its product. Benchling’s website leads with the work a scientist might ask its agents to do — plan cloning, analyse batch records, compare study results — rather than with pictures of laboratories, and it groups its offer by scientific area: antibodies and proteins, cell therapy, gene therapy, RNA therapeutics and microbial strains.

Ownership has stayed simple. Benchling, Inc. remains privately held and headquartered in San Francisco; Wikipedia records its regional bases in Boston, Zurich and Belfast. Its growth has come through venture funding and small acquisitions such as Overwatch Research in 2022 and PipeBio in 2024, rather than through a merger with a larger group.

For a design guide, Benchling shows how a laboratory software company can build a brand around a single cloud product and a one-line mission, carried from a student project to an enterprise platform. Compare Dotmatics, another maker of scientific data software, and LabVantage, a maker of laboratory information management systems. For this guide we use a deep ink, a steady blue and a pale mint with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Benchling’s identity on hand — save it to a board in the Made Good inspiration library.